Prolotherapy with Phenol recalled over sterility concerns
- Recall date
- August 17, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Hartley Medical Center Pharmacy, Incorporated recalls Prolotherapy with Phenol (Dextrose 25%, Glycerin 10%, Lidocaine HCl 10%, Bupivacaine HCl 0.625%, Phenol 1%, QS SWI), 5…
- Recall number
- D-1829-2015
- FDA classification
- Class I
- Brand / firm
- Hartley Medical Center Pharmacy, Incorporated
- Sold / distributed
- CA and NV
Why it was recalled
Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Prolotherapy with Phenol (Dextrose 25%, Glycerin 10%, Lidocaine HCl 10%, Bupivacaine HCl 0.625%, Phenol 1%, QS SWI), 5 mL vial, Rx Only, Hartley Medical, (888) 671-2888
Get recall alerts
Free email alert whenever Hartley Medical Center Pharmacy, Incorporated has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hartley Medical Center Pharmacy, Incorporated